Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06325332
Status:
RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-03-15
Brief Title:
BEYFORTUS Nirsevimab Effectiveness Against Medically-Attended RSV Events in Infants BEAR Study
Sponsor:
Sanofi Pasteur a Sanofi Company
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
RSV00080
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sanofi Pasteur a Sanofi Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None